Synairgen Plc (SNG) – Company Profile and SWOT Analysis

Synairgen Plc (SNG) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Synairgen Plc (Synairgen) is a biotechnology company. It is developing innovative therapies for respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD) and viral infections like COVID-19. The company’s product pipeline includes SNG001, an investigational inhaled interferon beta (IFN-ß) aimed at treating severe viral lung infections by enhancing the body’s antiviral defense. Synairgen’s technological base includes a Biobank with clinical samples from asthma and COPD volunteers, which supports the creation of advanced human disease models and tissue engineering platforms. These models aid in discovering drug targets and supporting clinical trials. Synairgen is headquartered in Southampton, England, United Kingdom.

Scope

• Detailed information on Synairgen Plc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Synairgen Plc in the form of a SWOT analysis

• An in-depth view of the business model of Synairgen Plc including a breakdown and examination of key business segments

• News about Synairgen Plc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Synairgen Plc and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Synairgen Plc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Synairgen Plcs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Halo Therapeutics Ltd

Novartis AG

GSK plc

Oxagen Ltd

Theravance Biopharma Inc

Napp Pharmaceuticals Ltd

Verona Pharma Plc

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Synairgen Plc - Key Facts

Synairgen Plc - Key Employees

Synairgen Plc - Key Employee Biographies

Synairgen Plc - Major Products and Services

Synairgen Plc - History

Synairgen Plc - Company Statement

Synairgen Plc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Synairgen Plc - Business Description

Synairgen Plc - Corporate Strategy

Synairgen Plc - SWOT Analysis

SWOT Analysis - Overview

Synairgen Plc - Strengths

Synairgen Plc - Weaknesses

Synairgen Plc - Opportunities

Synairgen Plc - Threats

Synairgen Plc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Synairgen Plc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024

Synairgen Plc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024

Synairgen Plc, Recent Deals Summary

Section 5 – Company’s Recent Developments

Sep 18, 2024: Synairgen : Appointment of New Chairman and Notice of AGM

Sep 18, 2024: Synairgen Announces Appointment of New Chairman and Notice of AGM

Sep 05, 2024: Synairgen Announces Board Change

Jun 27, 2024: Synairgen : Results for the year ended 31 December 2023

Oct 11, 2023: Synairgen : Appointment of Joseph Colliver as New Chief Financial Officer

Oct 03, 2023: Synairgen plc Appointment of Chief Medical Officer

Sep 21, 2023: Synairgen Announces Interim results for the Six Months Ended 30 June 2023

May 23, 2023: Synairgen plc Posting of Annual Report and Notice of AGM

Apr 17, 2023: Synairgen plc Notice of Full Year results

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Synairgen Plc, Key Facts

Synairgen Plc, Key Employees

Synairgen Plc, Key Employee Biographies

Synairgen Plc, Major Products and Services

Synairgen Plc, History

Synairgen Plc, Subsidiaries

Synairgen Plc, Key Competitors

Synairgen Plc, Ratios based on current share price

Synairgen Plc, Annual Ratios

Synairgen Plc, Annual Ratios (Cont…1)

Synairgen Plc, Interim Ratios

Synairgen Plc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024

Synairgen Plc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024

Synairgen Plc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Synairgen Plc, Ratio Charts

Synairgen Plc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024

Synairgen Plc, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

    Pricing

Quick Buy
Add to basket Enquire before buying

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports